MAM
IONS icon

Meeder Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

Meeder Asset Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.4K Sell
152
-564
-79% -$44.5K ﹤0.01% 665
2025
Q4 		$56.6K Buy
716
+3
+0.4% +$226 ﹤0.01% 380
2025
Q3 		$46.6K Buy
713
+614
+620% +$30K ﹤0.01% 320
2025
Q2 		$3.91K Buy
99
+4
+4% +$131 ﹤0.01% 746
2025
Q1 		$2.87K Buy
+95
New +$3.11K ﹤0.01% 838
2022
Q4 		– Sell
-186
Closed -$8K – 1371
2022
Q3 		$8K Hold
186
– – ﹤0.01% 1403
2022
Q2 		$7K Hold
186
– – ﹤0.01% 1511
2022
Q1 		$7K Buy
+186
New +$6.09K ﹤0.01% 1676
2021
Q4 		– Sell
-14
Closed – – 1731
2021
Q3 		$0 Hold
14
– – ﹤0.01% 2554
2021
Q2 		$1K Hold
14
– – ﹤0.01% 2346
2021
Q1 		$1K Buy
14
+1
+8% +$56 ﹤0.01% 2217
2020
Q4 		$1K Sell
13
-18
-58% -$897 ﹤0.01% 1669
2020
Q3 		$1K Sell
31
-30
-49% -$1.67K ﹤0.01% 1990
2020
Q2 		$4K Buy
61
+19
+45% +$1.06K ﹤0.01% 1587
2020
Q1 		$2K Sell
42
-3,574
-99% -$199K ﹤0.01% 2092
2019
Q4 		$219K Buy
3,616
+3,562
+6,596% +$212K 0.01% 577
2019
Q3 		$3K Buy
54
+27
+100% +$1.76K ﹤0.01% 1878
2019
Q2 		$2K Sell
27
-2,229
-99% -$158K ﹤0.01% 1863
2019
Q1 		$184K Buy
+2,256
New +$146K 0.01% 563
2018
Q3 		– Sell
-112
Closed -$4.67K – 1611
2018
Q2 		$4.67K Buy
+112
New +$4.96K ﹤0.01% 1290
2018
Q1 		– Sell
-309
Closed -$16K – 1640
2017
Q4 		$16K Buy
309
+265
+602% +$14.5K ﹤0.01% 995
2017
Q3 		$2K Buy
+44
New +$2.31K ﹤0.01% 1456
2017
Q2 		– Sell
-410
Closed -$16K – 1760
2017
Q1 		$16K Sell
410
-1,333
-76% -$59.9K ﹤0.01% 759
2016
Q4 		$83K Buy
+1,743
New +$69K 0.01% 540

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meeder Asset Management's IONS Position: Q1 2026 in Review

Meeder Asset Management reduced its Ionis Pharmaceuticals (IONS) stake by 79% in Q1 2026, selling an estimated $44.5K and leaving 152 shares worth $11.4K. The position accounts for ﹤0.01% of the portfolio, ranked #665.

Meeder Asset Management first reported a position in IONS in Q4 2016 and has held it in 24 quarters since. The position peaked at $219K in Q4 2019. 494 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • Meeder Asset Management held 152 shares of Ionis Pharmaceuticals worth $11.4K as of Q1 2026.
  • Meeder Asset Management sold 564 Ionis Pharmaceuticals shares in Q1 2026, an estimated $44.5K.
  • Ionis Pharmaceuticals made up ﹤0.01% of Meeder Asset Management's portfolio in Q1 2026, its #665 holding.
  • Meeder Asset Management first reported a position in Ionis Pharmaceuticals in Q4 2016 and has held it in 24 quarters since.
  • Meeder Asset Management's Ionis Pharmaceuticals position peaked at $219K in Q4 2019.
  • 494 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on Meeder Asset Management's 13F filing for Q1 2026, filed 7 May 2026.